MAPT and tauopathy: Inhibition of astrocytic α2-Na+/K+ adenosine triphosphatase (α2-NKA) in a mouse model of tauopathy suppresses neuroinflammation, and its knockdown halts the progression of tau pathology (Mann et al., 2022).